1. bookVolume 57 (2018): Edition 4 (January 2018)
Détails du magazine
Première parution
01 Mar 1961
4 fois par an
Anglais, Polonais
Accès libre


Publié en ligne: 26 Feb 2022
Volume & Edition: Volume 57 (2018) - Edition 4 (January 2018)
Pages: 301 - 312
Reçu: 01 Apr 2018
Accepté: 01 Sep 2018
Détails du magazine
Première parution
01 Mar 1961
4 fois par an
Anglais, Polonais

Abbaszadeh A., Darabi S., Hasanvand A., Amini-Khoei H., Abbasnezhad A., Choghakhori R., Aaliehpour A.: Minocycline through attenuation of oxidative stress and inflammatory response reduces the neuropathic pain in a rat model of chronic constriction injury. Iran. J. Basic Med. Sci. 21, 138–144 (2018)Search in Google Scholar

Bajaj J.S., Gillevet P.M. i wsp.: Modulation of the microbiome by rifaximin in patients with cirrhosis and minimal hepatic encephalopathy. PLoS ONE,8, e60042 (2013)10.1371/journal.pone.0060042Search in Google Scholar

Banh H.L.: Unconventional treatment options in severe asthma: an overview. J. Pharm. Pharm. Sci. 14, 387–399 (2011)Search in Google Scholar

Beker B., Mujica V., Guelrud M.: Effect of erythromycin on the sphincter of Oddi in healthy volunteers. Gastroenterology, 100, A309 (1991)Search in Google Scholar

Broad J., Sanger G.J.: The antibiotic azithromycin is a motilin receptor agonist in human stomach: comparison with erythromycin. Brit. J. Pharmacol. 168, 1859–1867 (2013)Search in Google Scholar

Calanni F., Renzulli C., Barbanti M., Viscomi G.C.: Rifaximin: beyond the traditional antibiotic activity. J. Antibiot. 67, 667– 670 (2014)10.1038/ja.2014.106Search in Google Scholar

Carbonell N., Pauwels A., Serfaty L., Boelle P.Y., Becquemont L, Poupon R: Erythromycin infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. Am. J. Gastroenterol. 101, 1211–1215 (2006)10.1111/j.1572-0241.2006.00582.xSearch in Google Scholar

Carsenti-Dellamonica H., Galimand M., Vandenbos F., Pradier C., Roger P.M., Dunais B., Sabah M., Mancini G., Dellamonica P.: In vitro selection of mutants of Streptococcus pneumoniae resistant to macrolides and linezolid: relationship with susceptibility to penicillin G and macrolides. J. Antimicrob. Chemother. 56, 633–642 (2005)10.1093/jac/dki301Search in Google Scholar

Catnach S.M., Fairclough P.D., Trembath R.C., O’Donnell L.J.D., McLean A.M., Law P.A., Wickham J.E.A.: Effect of oral erythromycin on gallbladder motility in normal and gallstone subjects. Gastroenterology, 102, 2071–2076 (1992)10.1016/0016-5085(92)90334-USearch in Google Scholar

Cheng J., Shah Y.M., Gonzalez F.J.: Pregnane X receptor as a target for treatment of inflammatory bowel disorders. Trends Pharmacol. Sci. 33, 323–330 (2012)Search in Google Scholar

Cherrill D.A., Stote R.M., Birge J.R., Singer I.: Demeclocycline treatment in the syndrome of inappropriate antidiuretic hormone secretion. Ann. Int. Med. 83, 654–656 (1975)Search in Google Scholar

Chini P., Toskes P.P., Waseem S., Hou W., McDonald R., Moshiree B.: Effect of azithromycin on small bowel motility in patients with gastrointestinal dysmotility. Scand. J. Gastroenterol. 47, 422–427 (2012)Search in Google Scholar

Choi Y., Suh Y.H. i wsp.: Minocycline attenuates neuronal cell death and improves cognitive impairment in Alzheimer’s disease models. Neuropsychopharmacology, 32, 2393–2404 (2007)10.1038/sj.npp.130137717406652Search in Google Scholar

Coffin B., Valleur P. i wsp.: Erythromycin improves the quality of EGD in patients with acute upper GI bleeding: a randomized controlled study. Gastrointest. Endosc. 56, 174–179 (2002)Search in Google Scholar

Curry J.I., Lander T.D., Stringer M.D.: Review article: erythromycin as a prokinetic agent in infants and children. Aliment. Pharmacol. Ther. 15, 595–603 (2001)Search in Google Scholar

Dall’Antonia M., Wilks M., Coen P.G., Bragman S., Millar M.R.: Erythromycin for prokinetics: imprudent prescribing? Crit. Care, 10, 112 (2006)10.1186/cc3956155083516420656Search in Google Scholar

De Francesco E.M., Bonuccelli G., Maggiolini M., Sotgia F., Lisanti M.P.: Vitamin C and Doxycycline: A synthetic lethal combination therapy targeting metabolic flexibility in cancer stem cells (CSCs). Oncotarget, 40, 67269–67286 (2017)10.18632/oncotarget.18428562017228978032Search in Google Scholar

De Francesco E.M., Maggiolini M., Tanowitz H.B., Sotgia F., Lisanti M.P.: Targeting hypoxic cancer stem cells (CSCs) with Doxycycline: Implications for optimizing anti-angiogenic therapy. Oncotarget, 34, 56126–56142 (2017)10.18632/oncotarget.18445559354928915578Search in Google Scholar

Demoly P., Gueron B., Annunziata K., Adamek L., Walters R.D.: Update on asthma control in five European countries: results of a 2008 survey. Eur. Respir. Rev. 116, 150–157 (2010)10.1183/09059180.0000211020956184Search in Google Scholar

Depoortere I., Peeters T.L., Matthijs G., Vantrappen G.: Macrolides antibiotics are motilin receptor agonists. Hepatogastroen-terology, 35, 198 (1988)Search in Google Scholar

Doherty W.L., Winter B.: Prokinetic agents in critical care. Crit. Care, 7, 206–208 (2003)Search in Google Scholar

Fox C., Dingman A., Derugin N., Wendland M.F., Manabat C., Ji S., Ferriero D.M., Vexler Z.S.: Minocycline confers early but transient protection in the immature brain following focal cerebral ischemia-reperfusion. J. Cereb. Blood Flow Metab. 25, 1138–1149 (2005)10.1038/sj.jcbfm.9600121226209715874975Search in Google Scholar

Frossard J.L., Spahr L., Queneau P.E., Giostra E., Burckhardt B., Ory G., De Saussure P., Armenian B., De Peyer R., Hadengue A.: Erythromycin intravenous bolus infusion in acute upper gastrointestinal bleeding: a randomized, controlled, double blind trial. Gastroenterology, 123, 17–23 (2002)10.1053/gast.2002.3423012105828Search in Google Scholar

German-Fattal M.: Fusafungine, an antimicrobial with anti-inflammatory properties in respiratory tract infections – review and recent advances in cellular and molecular activity. Clin. Drug Investig. 21, 653–670 (2001)10.2165/00044011-200121090-00007Search in Google Scholar

Goh K.P.: Management of hyponatremia. Am. Fam. Physician, 69, 2387–2394 (2004)Search in Google Scholar

Golub L.M., Goodson J.M., Lee H.M., Vidal A.M., McNamara T.F., Ramamurthy N.S.: Tetracyclines Inhibit Tissue Collagenases: Effects of Ingested Low-Dose and Local Delivery Systems. J. Periodontol. 56, 93–97 (1985)10.1902/jop.1985.56.11s.933001266Search in Google Scholar

Golub L.M., Lee H.M., Ryan M.E., Giannobile W.V., Payne J., Sorsa T.: Tetracyclines inhibit connective tissue breakdown by multiple non-antimicrobial mechanisms. Adv. Dent. Res. 12, 12–26 (1998)Search in Google Scholar

Golub L.M., McNamara T.F., Ryan M.E., Kohut B., Blieden T., Payonk G., Sipos T., Baron H.J.: Adjunctive treatment with subantimicrobial doses of doxycycline: effects on gingival fluid collagenase activity and attachment loss in adult periodontitis. J. Clin. Periodontol. 28, 146–156 (2001)10.1034/j.1600-051x.2001.028002146.x11168739Search in Google Scholar

Gu Y., Lee H.M., Sorsa T., Simon S.R., Golub L.M.: Doxycycline inhibits mononuclear cell-mediated connective tissue breakdown. FEMS Immunol. Med. Microbiol. 58, 218–225 (2010)Search in Google Scholar

Hahn D.L., Grasmick M., Hetzel S., Yale S.: Azithromycin for bronchial asthma in adults: an effectiveness trial. J. Am. Board Fam. Med. 25, 442–459 (2012)Search in Google Scholar

Hahn D.L., Plane M.B., Mahdi O.S., Byrne G.I.: Secondary Outcomes of a Pilot Randomized Trial of Azithromycin Treatment for Asthma. PLoS Clin. Trials, 2, e11, (2006)Search in Google Scholar

Hatipoglu U., Rubinstein I.: Low-dose, long-term macrolide therapy in asthma: An overview. Clin. Mol. Allergy, 2, 4 (2004)Search in Google Scholar

Hu Y.Y., Xu J., Zhang M., Wang D., Li L., Li W.B.: Ceftriaxone modulates uptake activity of glial glutamate transporter-1 against global brain ischemia in rats. J. Neurochem. 132, 194–205 (2015)10.1111/jnc.1295825270764Search in Google Scholar

Itoh Z., Nakaya M., Suzuki T., Arai H., Wakabayashi K.: Erythromycin mimics exogenous motilin in gastrointestinal contractile activity in the dog. Am. J. Physiol. 247, G688–694 (1984)10.1152/ajpgi.1984.247.6.G6886507625Search in Google Scholar

Jalal F.Y., Yang Y., Thompson J.F., Roitbak T., Rosenberg G.A.: Hypoxia-induced neuroinflammatory white-matter injury reduced by minocycline in SHR/SP. J. Cereb. Blood Flow Metab. 35, 1145–1153 (2015)10.1038/jcbfm.2015.21464026525712499Search in Google Scholar

Janssens J., Vantrappen G., Annese V., Peeters T.L., Tijskens G., Rekoumis G.: Effect of erythromycin on LES function and oesophageal body contractility. Gastroenterology, 98, A64 (1990)Search in Google Scholar

Jesionowska A., Cecerska-Heryć E., Marczuk N., Safronow K., Dołęgowska B.: Kwas lizofosfatydowy w nowotworach złośliwych. Postępy Biochemii, 4, 381–387 (2015)Search in Google Scholar

Jiang Z.D., Ke S., DuPont H.L.: Rifaximin-induced alteration of virulence of diarrhea-producing Escherichia coli and Shigella sonnei. Int. J. Antimicrob. Agents, 35, 278–281 (2010)10.1016/j.ijantimicag.2009.11.01320045287Search in Google Scholar

John R., Brazier J.S.: Antimicrobial susceptibility of polymerase chain reaction ribotypes of Clostridium difficile commonly isolated from symptomatic hospital patients in the UK. J. Hosp. Infect. 61, 11–14 (2005)10.1016/j.jhin.2005.01.02016002183Search in Google Scholar

Johnston S.L., Chauhan A. i wsp.: Azithromycin for Acute Exacerbations of Asthma: The AZALEA Randomized Clinical Trial. JAMA Intern. Med. 176, 1630–1637 (2016)Search in Google Scholar

Kajander K., Myllyluoma E., Kyrönpalo S., Rasmussen M., Sipponen P., Mattila I., Seppänen-Laakso T., Vapaatalo H., Oresic M., Korpela R.: Elevated pro-inflammatory and lipotoxic mucosal lipids characterise irritable bowel syndrome. World J. Gastroenterol. 15, 6068–6074 (2009)Search in Google Scholar

Kalambokis G.N., Mouzaki A., Rodi M., Pappas K., Fotopoulos A., Xourgia X., Tsianos E.V.: Rifaximin improves systemic hemodynamics and renal function in patients with alcohol-related cirrhosis and ascites. Clin. Gastroenterol. Hepatol. 10, 815–818 (2012)Search in Google Scholar

Kew K.M., Undela K., Kotortsi I., Ferrara G.: Macrolides for chronic asthma. Cochrane Database Syst. Rev. 9, CD002997 (2015)10.1002/14651858.CD002997.pub426371536Search in Google Scholar

Kliewer S.A., Goodwin B., Willson T.M.: The nuclear pregnane X receptor: a key regulator of xenobiotic metabolism. Endocr. Rev. 23, 687–702 (2002)10.1210/er.2001-003812372848Search in Google Scholar

Krzyżanowska W., Pomierzy B., Budziszewska B., Filip M., Pera J.: N-Acetylcysteine and Ceftriaxone as Preconditioning Strategies in Focal Brain Ischemia: Influence on Glutamate Transporters Expression. Neurotox. Res. 29, 539–550 (2016)10.1007/s12640-016-9602-z482048326861954Search in Google Scholar

Ksiądzyna D.: Zaburzenia czynnościowe żołądka i dwunastnicy (w) Zaburzenia czynnościowe przewodu pokarmowego, red. L. Paradowski, Cornetis, Wrocław, 2012, s. 89–104Search in Google Scholar

Ksiądzyna D.: Wpływ innych chorób na czynność przewodu pokarmowego – gastropareza (w) Zaburzenia czynnościowe przewodu pokarmowego, red. L. Paradowski, Cornetis, Wrocław, 2012, s. 213–227Search in Google Scholar

Lee G.J., Lim J.J., Hyun S.: Minocycline treatment increases resistance to oxidative stress and extends lifespan in Drosophila via FOXO. Oncotarget, 50, 87878–87890 (2017)10.18632/oncotarget.21224567567929152127Search in Google Scholar

Lee S.G., Su Z.Z., Emdad L., Gupta P., Sarkar D., Borjabad A., Volsky D.J., Fisher P.B.: Mechanism of ceftriaxone induction of excitatory amino acid transporter-2 expression and glutamate uptake in primary human astrocytes. J. Biol. Chem. 283, 13116–13123 (2008)Search in Google Scholar

Lehtola J., Jauhonen P., Kesaniemi A., Wikberg R., Gordin A.: Effect of erythromycin on the oro-caecal transit time in man. Eur. J. Clin. Pharmacol. 39, 555–558, (1990)10.1007/BF003160942095341Search in Google Scholar

Leung T.C.H., Lui C.N.P., Chen L.W., Yung W.H., Chan Y.S., Yung K.K.L.: Ceftriaxone ameliorates motor deficits and protects dopaminergic neurons in 6-hydroxydopamine-lesioned rats. ACS Chem. Neurosci. 3, 22–30 (2012)Search in Google Scholar

Leung W.K., Chan F.K.L., Fung S.S.L., Wong M.Y., Sung J.J.Y.: Effect of oral erythromycin on gastric and small bowel transit time of capsule endoscopy. World J. Gastroenterol.11, 4865–4868 (2005)10.3748/wjg.v11.i31.4865439873816097060Search in Google Scholar

Lewerenz J., Albrecht P., Tien M.L., Henke N., Karumbayaram S., Kornblum H.I., Wiedau-Pazos M., Schubert D., Maher P., Methner A.: Induction of Nrf2 and xCT are involved in the action of the neuroprotective antibiotic ceftriaxone in vitro. J. Neurochem. 111, 332–243 (2009)10.1111/j.1471-4159.2009.06347.x19694903Search in Google Scholar

Liebregts T., Holtman G. i wsp.: Immune activation in patients with irritable bowel syndrome. Gastroenterology, 132, 913–920 (2007)10.1053/j.gastro.2007.01.04617383420Search in Google Scholar

Lund V.J., Grouin J.M., Eccles R., Bouter C., Chabolle F.: Efficacy of fusafungine in acute rhinopharyngitis: a pooled analysis. Rhinology, 42, 207–212 (2004)Search in Google Scholar

Marek T., Baniukiewicz A., Wallner G., Rydzewska G., Dąbrowski A.: Wytyczne postępowania w krwawieniu z górnego odcinka przewodu pokarmowego pochodzenia nieżylakowego. Prz. Gastroenterol. 3, 1–22 (2008)Search in Google Scholar

Matsumoto T., Uchiumi T., Monji K., Yagi M., Setoyama D., Amamoto R., Matsushima Y., Shiota M., Eto M., Kang D.: Doxycycline induces apoptosis via ER stress selectively to cells with a cancer stem cell-like properties: importance of stem cell plasticity. Oncogenesis, 11, 397 (2017)10.1038/s41389-017-0009-3586805829184058Search in Google Scholar

McGuire J.M., Bunch R.L., Anderson R.C., Boaz H.E., Flynn E.H., Powell H.M., Smith J.W.: "Ilotycin”, a new antibiotic. Antibiot. Chemother. 2, 281 (1952)Search in Google Scholar

Menzel M., Akbarshahi H., Tufvesson E., Persson C., Bjermer L., Uller L.: Azithromycin augments rhinovirus-induced IFNβ via cytosolic MDA5 in experimental models of asthma exacerbation. Oncotarget, 19, 31601–31611 (2017)10.18632/oncotarget.16364545823328415826Search in Google Scholar

Mertens V., Blondeau K., Pauwels A., Farre R., Vanaudenaerde B., Vos R., Verleden G., Van Raemdonck D.E., Dupont L.J., Sifrim D.: Azithromycin reduces gastroesophageal reflux and aspiration in lung transplant recipients. Dig. Dis. Sci. 54, 972–979 (2009)Search in Google Scholar

Miell J., Dhanjal P., Jamookeeah C.: Evidence for the use of demeclocycline in the treatment of hyponatraemia secondary to SIADH: a systematic review. Int. J. Clin. Pract. 69, 1396–1417 (2015)10.1111/ijcp.12713504209426289137Search in Google Scholar

Min Y., Li F. i wsp.: Minocycline-Suppression of Early Peripheral Inflammation Reduces Hypoxia-Induced Neonatal Brain Injury. Front. Neurosci. 11, 511 (2017)10.3389/fnins.2017.00511560096228955196Search in Google Scholar

Moini-Zanjani T., Ostad S.N., Labibi F., Ameli H., Mosaffa N., Sabetkasaei M.: Minocycline Effects on IL-6 Concentration in Macrophage and Microglial Cells in a Rat Model of Neuropathic Pain. Iran. Biomed. J. 20, 273–279 (2016)Search in Google Scholar

Mullany P., Wilks M., Tabaqchali S.: Transfer of macrolide-lincosamide – streptogramin B (MLS) resistance in Clostridium difficile is linked to a gene homologous with toxin A and is mediated by a conjugative transposon Tn5398. J. Antimicrob. Chemother. 35, 305–315 (1995)10.1093/jac/35.2.3057759394Search in Google Scholar

Peeters T., Matthijs G., Depoortere I., Cachet T., Hoogmartens J., Vantrappen G.: Erythromycin is a motilin receptor agonist. Am. J. Physiol. 257, G470–G474 (1989)10.1152/ajpgi.1989.257.3.G4702782416Search in Google Scholar

Peiris-Pagès M., Sotgia F., Lisanti M.P.: Doxycycline and therapeutic targeting of the DNA damage response in cancer cells: old drug, new purpose. Oncoscience, 8, 696–699 (2015)10.18632/oncoscience.215458006226425660Search in Google Scholar

Pietrzak A., Bartnik W., Szczepkowski M., Krokowicz P., Dziki A., Reguła J., Wallner G.: Polish interdisciplinary consensus on diagnostics and treatment of colonic diverticulosis. Pol. Przeg. Chir. 87, 203–220 (2015)Search in Google Scholar

Pilot M.A., Ritchie H.D., Thompson H., Zara G.P.: Alterations in gastrointestinal motility associated with erythromycin. Br. J. Pharmacol. 81: 168P (1984)Search in Google Scholar

Pimentel M., Forbes W.P. i wsp.: Rifaximin therapy for patients with irritable bowel syndrome without constipation. N. Engl. J. Med. 364, 22–32 (2011)Search in Google Scholar

Pimentel M.: Review article: potential mechanisms of action of rifaximin in the management of irritable bowel syndrome with diarrhoea. Aliment. Pharmacol. Ther. 43Suppl. 1, 37–49 (2016)Search in Google Scholar

Pimentel M., Cash B.D., Limbo A., Wolf R.A., Israel R.J., Schoenfeld P.: Repeat rifaximin for irritable bowel syndrome: no clinical significant changes in stool microbial antibiotic sensitivity. Dig. Dis. Sci. 62, 2455–2463 (2017)Search in Google Scholar

Qin Y., Zhou H.G. i wsp.: Doxycycline reverses epithelial-to-me-senchymal transition and suppresses the proliferation and metastasis of lung cancer cells. Oncotarget, 38, 40667–40679 (2015)Search in Google Scholar

Reiter J., Demirel N., Mendy A., Gasana J., Vieira E.R., Colin A.A., Quizon A., Forno E.: Macrolides for the long-term management of asthma – a meta-analysis of randomized clinical trials. Allergy, 68, 1040–1049 (2013)10.1111/all.1219923895667Search in Google Scholar

Richards R.D., Davenport K.G., Hurm K.D., Wimbish W.R., McCallum R.W.: Acute and chronic treatment of gastroparesis with erythromycin. Gastroenterology, 98, A385 (1990)Search in Google Scholar

Rifkin B.R., Vernillo A.T., Golub L.M.: Blocking Periodontal Disease Progression by Inhibiting Tissue-Destructive Enzymes: A Potential Therapeutic Role for Tetracyclines and Their Chemically-Modified Analogs. Journal of Periodontology, 64, 819–827 (1993)10.1902/jop.1993.64.8s.8198410621Search in Google Scholar

Rohof W.O., Bennink R.J., Ruigh A.A., Hirsch D.P., Zwinderman A.H., Boeckxstaens G.E.: Effect of azithromycin on acid reflux, hiatus hernia and proximal acid pocket in the postprandial period. Gut, 61, 1670–1677 (2012)10.1136/gutjnl-2011-30092622267599Search in Google Scholar

Rothstein J.D., Fisher P.B. i wsp.: Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression. Nature, 7021, 73–77 (2005)Search in Google Scholar

Ruzza P., Sechi G. i wsp.: Ceftriaxone blocks the polymerization of α-synuclein and exerts neuroprotective effects in vitro. ACS Chem. Neurosci. 5, 30–38 (2014)Search in Google Scholar

Sarna S.K., Lee M.B. i wsp.: Effects of erythromycin on human gastrointestinal motor activity in the fed and fasted states. Gastroenterology, 96, A440 (1989)Search in Google Scholar

Scholz R., Sobotka M., Caramoy A., Stempfl A., Moehle C., Langmann T.: Minocycline counter-regulates pro-inflammatory microglia responses in the retina and protects from degeneration. J. Neuroinflammation, 12: 209 (2015)10.1186/s12974-015-0431-4465086626576678Search in Google Scholar

Secko D.: Antibiotics that protect the brain. CMAJ172, 467–468 (2005)10.1503/cmaj.05002254840415710934Search in Google Scholar

Sherlock M., Thompson C.J.: The syndrome of inappropriate antidiuretic hormone: current and future management options. Eur. J. Endocrinol. 162Suppl. 1, S13–88 (2010)10.1530/EJE-09-1057Search in Google Scholar

Shlopov B.V., Stuart J.M., Gumanovskaya M.L., Hasty K.A.: Regulation of cartilage collagenase by doxycycline. J. Rheumatol. 28, 835–842 (2001)Search in Google Scholar

Smith G.N. Jr., Yu L.P. Jr., Brandt K.D., Capello W.N.: Oral administration of doxycycline reduces collagenase and gelatinase activities in extracts of human osteoarthritic cartilage. J. Rheumatol. 25, 532–535 (1998)Search in Google Scholar

Sorsa T., Tervahartiala T., Leppilahti J., Hernandez M., Gamonal J., Tuomainen A.M., Lauhio A., Pussinen P.J., Mäntylä P.: Collagenase-2 (MMP-8) as a point-of-care biomarker in periodontitis and cardiovascular diseases. Therapeutic response to non-antimicrobial properties of tetracyclines. Pharmacol. Res. 63, 108–113 (2011)10.1016/j.phrs.2010.10.005Search in Google Scholar

Spasovski G., Nagler E. i wsp.: Clinical practice guidelines on diagnosis and treatment of hyponatremia. Eur. J. Endocrinol. 170, G1–47 (2014)10.1530/EJE-13-1020Search in Google Scholar

Stallinger S., Eller N., Högenauer C.: Non-interventional study evaluating efficacy and tolerability of rifaximin for treatment of uncomplicated diverticular disease. Wiener Klin. Wochenschr. 126, 9–14 (2014)Search in Google Scholar

Sturm A., Holtmann G., Goebell H., Gerken G.: Prokinetics in patients with gastroparesis: a systematic analysis. Digestion, 60, 422–427 (1999)10.1159/000007687Search in Google Scholar

Sy-Cordero A.A., Pearce C.J., Oberlies N.H.: Revisiting the enniatins: a revive of their isolation, biosynthesis, structure determination, and biological activities. J. Antibiot. 65, 541–549 (2012)10.1038/ja.2012.71Search in Google Scholar

Talley N.J., Verlinden M., Geenen D.J., Hogan R.B., Riff D., McCallum R.W., Mack R.J.: Effects of a motilin receptor agonist (ABT-229) on upper gastrointestinal symptoms in type 1 diabetes mellitus: a randomized, double blind, placebo controlled trial. Gut, 49, 395–401 (2001)10.1136/gut.49.3.395Search in Google Scholar

Tang X., Wang X., Zhao Y.Y., Curtis J.M., Brindley D.N.: Doxycycline attenuates breast cancer related inflammation by decreasing plasma lysophosphatidate concentrations and inhibiting NF-κB activation. Mol. Cancer, 16, 36 (2017)10.1186/s12943-017-0607-xSearch in Google Scholar

Vezina C., Kudelski A., Sehgal S.N.: Rapamycin (AY-22, 989), a new antifungal antibiotic. I. Taxonomy of the producing strep-tomycete and isolation of the active principle. J. Antibiot. 28, 721–726 (1975)10.7164/antibiotics.28.721Search in Google Scholar

Wang Z., Nong J., Shultz R.B., Zhang Z., Kim T., Tom V.J., Ponnappan R.K., Zhong Y.: Local delivery of minocycline from metal ion-assisted self-assembled complexes promotes neuroprotection and functional recovery after spinal cord injury. Biomaterials, 112, 62–71 (2017)10.1016/j.biomaterials.2016.10.002Search in Google Scholar

Warny M., Pepin J., Fang A., Killgore G., Thompson A., Brazier J., Frost E., McDonald L.C.: Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet, 366, 1079–1084 (2005)10.1016/S0140-6736(05)67420-XSearch in Google Scholar

Webley W.C., Hahn D.L.: Infection-mediated asthma: etiology, mechanisms and treatment options, with focus on Chlamydia pneumoniae and macrolides. Respiratory Res. 18, 98 (2017)10.1186/s12931-017-0584-z543765628526018Search in Google Scholar

Xu X., Gaggar A. i wsp.: Doxycycline improves clinical outcomes during cystic fibrosis exacerbations. Eur. Respir. J. 49, pii: 1601102 (2017)10.1183/13993003.01102-201628381428Search in Google Scholar

Zatmann T.F., Hall J.E., Harmer M.: Gastric residual volume in children: a study comparing efficiency of erythromycin and metoclopramide as prokinetic agents. Br. J. Anaesth. 86, 869–871 (2001)10.1093/bja/86.6.86911573597Search in Google Scholar

Zhang L., Xu L., Zhang F., Vlashi E.: Doxycycline inhibits the cancer stem cell phenotype and epithelial-to-mesenchymal transition in breast cancer. Cell Cycle, 16, 737–745 (2017)10.1080/15384101.2016.1241929540572927753527Search in Google Scholar

Zhong W., Yang C. i wsp.: Doxycycline inhibits breast cancer EMT and metastasis through PAR-1/NF-κB/miR-17/E-cadherin pathway. Oncotarget, 62, 104855-104866 (2017)Search in Google Scholar

Articles recommandés par Trend MD

Planifiez votre conférence à distance avec Sciendo